Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R15B And PIK3C2B Antisense RNA 1 (PPP1R15B-AS1)
- Target
- PPP1R15B-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
PPP1R15B And PIK3C2B Antisense RNA 1 is a long non-coding RNA gene that acts as an antisense regulator of its associated sense genes. Antisense lncRNAs regulate gene expression through multiple mechanisms, such as direct binding and stabilization of mRNA, modulating promoter methylation, and interfering with transcriptional machinery. These molecules do not encode proteins but have important epigenetic and regulatory roles in development, cellular stress responses, and disease. There are no current reports of PPP1R15B-AS1 being used as a therapeutic target or as a clinical biomarker, though antisense lncRNAs in general are being investigated for their roles and potential as drug targets or disease markers[3][4].
- Other names
- PPP1R15B-AS1AL606489.1
02
Mechanism of action
ASOs may degrade target lncRNA, modify splicing, inhibit translation, or alter chromatin structure—mechanisms are indirect and depend on context
03
Biological functions
Regulation of gene expression (via antisense interaction)Epigenetic regulationPossible involvement in transcriptional interference and chromatin modification
04
Disease associations
Not directly established for PPP1R15B-AS1; antisense lncRNAs in general play roles in cancer, development, and stress responses
05
Safety considerations
None specific to PPP1R15B-AS1; general therapeutic challenges for lncRNAs include off-target effects, delivery, and immune activation
06
Interacting drugs
Antisense oligonucleotides (ASOs)
07
Biomarkers
None directly listed for PPP1R15B-AS1; lncRNAs are emerging as potential biomarkers for cancer and other diseases, but specific evidence for this molecule is not currently described
Beyond the preview
Go deeper on PPP1R15B And PIK3C2B Antisense RNA 1 (PPP1R15B-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PPP1R15B And PIK3C2B Antisense RNA 1 (PPP1R15B-AS1).